Quintain NanoSystems

Quintain NanoSystems is a biotechnology company specializing in the development of porous silicon nanoparticle (pSiNP) technology for targeted drug delivery and diagnostics. Spun out of research from the University of California, San Diego, the company's platform is designed to improve the stability, loading capacity, and controlled release of therapeutic payloads, including small molecules and biologics. Their nanoparticles are biodegradable and biocompatible, offering a versatile solution for treating complex diseases such as cancer and ocular disorders. Quintain NanoSystems focuses on partnering with pharmaceutical companies to integrate its delivery solutions into novel drug development programs to enhance therapeutic efficacy and safety.